Healthcare -
Biotechnology - NASDAQ - US
$ 1.81
2.84 %
$ 1.15 B
Market Cap
-6.7
P/E
GERN - OPERATING EXPENSES
Operating Expenses GERN - Geron Corporation
194 M
LAST VALUE
29.72%
2 YEAR CAGR
43.30%
5 YEAR CAGR
17.48%
10 YEAR CAGR